News of the WeekGene Therapy

RAC Hears a Plea for Resuming Trials, Despite Cancer Risk

See allHide authors and affiliations

Science  14 Feb 2003:
Vol. 299, Issue 5609, pp. 991
DOI: 10.1126/science.299.5609.991b

You are currently viewing the summary.

View Full Text

Summary

After learning more about the leukemias in two patients in a French gene-therapy trial, a U.S. review panel this week suggested that although it makes sense to keep this trial on hold, others might be allowed to resume. The panel also learned that a third patient in the French trial has a gene insertion like the one in the two who developed leukemia--although this child does not have leukemia.